The US FDA has scheduled a Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting on October 06, 2022, to discuss the Strain Selection for the Influenza Virus Vaccines for the 2023 Southern Hemisphere Influenza Season.
Back to All Events
Earlier Event: September 23
Oncologic Drugs Advisory Committee
Later Event: October 17
Obstetrics, Reproductive, and Urologic Drugs Advisory Committee (ORUDAC)